| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases.
|
Mol Cell Biol
|
2002
|
4.50
|
|
2
|
MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease.
|
Cancer Prev Res (Phila)
|
2009
|
3.55
|
|
3
|
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.
|
Nat Genet
|
2003
|
3.38
|
|
4
|
The Aurora kinases: role in cell transformation and tumorigenesis.
|
Cancer Metastasis Rev
|
2003
|
2.64
|
|
5
|
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
|
Genome Res
|
2013
|
2.57
|
|
6
|
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.
|
Clin Cancer Res
|
2003
|
2.27
|
|
7
|
Retracted
BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition.
|
J Biol Chem
|
2004
|
1.77
|
|
8
|
Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A.
|
J Cell Biol
|
2010
|
1.60
|
|
9
|
Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells.
|
Cell Motil Cytoskeleton
|
2004
|
1.59
|
|
10
|
Aurora kinase inhibitors as anticancer molecules.
|
Biochim Biophys Acta
|
2010
|
1.33
|
|
11
|
Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents.
|
Bioorg Med Chem
|
2009
|
1.33
|
|
12
|
Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.
|
Clin Cancer Res
|
2010
|
1.31
|
|
13
|
p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells.
|
EMBO Rep
|
2002
|
1.30
|
|
14
|
Targeting aurora kinases as therapy in multiple myeloma.
|
Blood
|
2007
|
1.19
|
|
15
|
Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.
|
Head Neck
|
2009
|
1.17
|
|
16
|
Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
1.09
|
|
17
|
Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
|
J Natl Cancer Inst
|
2008
|
1.09
|
|
18
|
Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.
|
Oncol Res
|
2005
|
1.08
|
|
19
|
Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians.
|
Clin Cancer Res
|
2007
|
1.07
|
|
20
|
MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease.
|
J Biosci
|
2011
|
1.07
|
|
21
|
STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis.
|
Cancer
|
2004
|
1.06
|
|
22
|
Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle.
|
Nucleic Acids Res
|
2006
|
1.05
|
|
23
|
Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.
|
Int J Oncol
|
2004
|
1.02
|
|
24
|
Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73.
|
Cancer Cell
|
2012
|
1.02
|
|
25
|
Aurora kinase-A regulates kinetochore/chromatin associated microtubule assembly in human cells.
|
Cell Cycle
|
2008
|
0.99
|
|
26
|
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.
|
PLoS Med
|
2009
|
0.99
|
|
27
|
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation.
|
Ann Surg Oncol
|
2008
|
0.96
|
|
28
|
Association between Aurora-A kinase polymorphisms and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population.
|
Mol Carcinog
|
2007
|
0.94
|
|
29
|
A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors.
|
Cancer Res
|
2009
|
0.93
|
|
30
|
Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk.
|
Oral Oncol
|
2011
|
0.92
|
|
31
|
A migration signature and plasma biomarker panel for pancreatic adenocarcinoma.
|
Cancer Prev Res (Phila)
|
2010
|
0.91
|
|
32
|
Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer.
|
Cancer Lett
|
2008
|
0.90
|
|
33
|
Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.
|
Mol Carcinog
|
2013
|
0.90
|
|
34
|
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.
|
Int J Cancer
|
2013
|
0.89
|
|
35
|
Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes.
|
Oncogene
|
2003
|
0.89
|
|
36
|
A study on socio-demographic characteristics of alcoholics attending the de-addiction center at Burdwan medical college and hospital in West Bengal.
|
Indian J Public Health
|
2013
|
0.89
|
|
37
|
Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells.
|
Horm Cancer
|
2010
|
0.88
|
|
38
|
A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians.
|
Mol Carcinog
|
2011
|
0.84
|
|
39
|
Neurocognitive impairment in early HIV-positive individuals.
|
J Indian Med Assoc
|
2008
|
0.84
|
|
40
|
DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.
|
Cancer Discov
|
2013
|
0.83
|
|
41
|
Cytotoxic effects of ultra-diluted remedies on breast cancer cells.
|
Int J Oncol
|
2010
|
0.83
|
|
42
|
Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study.
|
Pancreas
|
2010
|
0.82
|
|
43
|
Aurora kinase-A deficiency during skin development impairs cell division and stratification.
|
J Invest Dermatol
|
2012
|
0.81
|
|
44
|
Aurora-A kinase phosphorylation of Aurora-A kinase interacting protein (AIP) and stabilization of the enzyme-substrate complex.
|
J Cell Biochem
|
2007
|
0.80
|
|
45
|
Functional significance of Aurora kinase A regulatory interactions with p53-ERα complex in human breast cancer cells.
|
Horm Cancer
|
2011
|
0.80
|
|
46
|
Aurora-A kinase nuclear expression in chronic lymphocytic leukemia.
|
Mod Pathol
|
2008
|
0.80
|
|
47
|
Tramadol versus clonidine in management of heroin withdrawl.
|
Asian J Psychiatr
|
2010
|
0.80
|
|
48
|
Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor alpha-mediated transcription.
|
Int J Oncol
|
2010
|
0.79
|
|
49
|
Synthesis of 1,2,3-triazole-linked pyrrolobenzodiazepine conjugates employing 'click' chemistry: DNA-binding affinity and anticancer activity.
|
Bioorg Med Chem Lett
|
2007
|
0.78
|
|
50
|
High-resolution melting analysis reveals genetic polymorphisms in microRNAs confer hepatocellular carcinoma risk in Chinese patients.
|
BMC Cancer
|
2014
|
0.78
|
|
51
|
Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer.
|
Pancreas
|
2011
|
0.78
|
|
52
|
Aurora-C: the youngest of "the three (Aurora kinase) tenors" of mitotic symphony.
|
Cell Cycle
|
2009
|
0.77
|
|
53
|
Synthesis, DNA-binding ability and evaluation of antitumour activity of triazolo[1,2,4]benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates.
|
Bioorg Med Chem
|
2008
|
0.76
|
|
54
|
Synthesis of aryl-substituted naphthalene-linked pyrrolobenzodiazepine conjugates as potential anticancer agents with apoptosis-inducing ability.
|
ChemMedChem
|
2011
|
0.76
|
|
55
|
Phosphonate-linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates: synthesis, DNA-binding affinity and cytotoxicity.
|
Bioorg Med Chem
|
2008
|
0.76
|
|
56
|
1,2,4-benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates: synthesis, DNA-binding affinity and cytotoxicity.
|
Bioorg Med Chem Lett
|
2007
|
0.76
|
|
57
|
Managing uncontrolled postsplenectomy reactive thrombocytosis in idiopathic thrombocytopenic purpura: role of thrombocytapheresis.
|
Transfus Apher Sci
|
2013
|
0.75
|
|
58
|
Design, synthesis and biological evaluation of 3,5-diaryl-isoxazoline/isoxazole-pyrrolobenzodiazepine conjugates as potential anticancer agents.
|
Eur J Med Chem
|
2010
|
0.75
|
|
59
|
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
|
Bioorg Med Chem Lett
|
2010
|
0.75
|
|
60
|
Synthesis, anticancer activity and mitochondrial mediated apoptosis inducing ability of 2,5-diaryloxadiazole-pyrrolobenzodiazepine conjugates.
|
Bioorg Med Chem
|
2010
|
0.75
|